Helen M. Blau
Academic Appointments
- Professor, Microbiology & Immunology - Baxter Laboratory
- Member, Bio-X
- Member, Stanford Cancer Institute
Key Documents
Contact Information
- Academic Offices
Personal Information Email Tel (650) 723-6209Alternate Contact Susan French Administrative Coordinator Email Tel Work 650-725-5090
Professional Overview
Administrative Appointments
- Director, Baxter Laboratory for Stem Cell Biology (2000 - present)
- Member, Institute for Stem Cell Biology and Regenerative Medicine (2004 - present)
- Faculty Affiliate, Bio-X Program (2005 - present)
- Faculty Affidiate, Stanford Cardiovascular Institute (2003 - present)
- Chair, Department of Molecular Pharmacology (1997 - 2002)
Honors and Awards
- Fulbright Senior Specialist, Institut Pasteur, Paris (2007)
- Board Member, Harvard Board of Overseers (2004-2010)
- Council Member, Institute of Medicine (IOM) (2003-2009)
- Plenary Lecturer, 400th Pontifical Academy, The Vatican (2003)
- Honorary Doctorate, University of Nijmegen, Holland (2003)
- Rolf-Sammet-Fonds Visiting Professorship, University of Frankfurt (2003)
Professional Education
| Ph.D.: | Harvard University (1975) |
| M.A.: | Harvard University (1970) |
| B.A.: | University of York (1969) |
Postdoctoral Advisees
Jennifer Brady, David Burns, Chia Yu Alex Chang, Benjamin Cosgrove, Russell Haynes, Thach Mai, Ermelinda Porpiglia
Graduate & Fellowship Program Affiliations
Internet Links
Scientific Focus
Current Research Interests
The question of fundamental interest to our laboratory is how cells maintain a quiescent, proliferative or differentiated state. Once a cell becomes specialized for function in a particular tissue, that differentiated state is stable, yet the molecular mechanisms that control the expression of its characteristic repertoire of genes are largely dynamic. Our research is directed at understanding this apparent paradox and elucidating the nature of cell memory and cell plasticity. By perturbing the intracellular or extracellular milieu, we are probing the regulatory network that determines cell fate and how it can be altered. This knowledge is key to our understanding of stem cell quiescence, self-renewal, differentiation, and how cancer arises. This information is also critical to the use of somatic cells or stem cells for therapeutic purposes.
Stem Cell Biology in Bioengineered Niches: we are using nanotechnology to study the role of extrinsic tethered and soluble factors in stem cell fate determination and self-renewal. Specifically, we are studying the effects over time of soluble components (growth factors, morphogens and cytokines) and tethered insoluble components (cell-cell adhesion and extracellular matrix components) on apoptosis, cell division, and differentiation of live single cells in hydrogel microwells by time lapse microscopy. We are elucidating the cell intrinsic molecular mechanisms that govern nuclear reprogramming critical to directing adult stem cell differentiation for use in cell based therapies. To study chromatin remodeling mechanisms necessary for reprogramming, we are using cell fusion and nuclear transfer approaches.
Technology Development for Elucidation of Regulatory Pathways: using technologies developed in our laboratory (restriction enzyme generated siRNAs (REGS) for loss of function analyses and beta-galactosidase assays of protein complementation for monitoring intracellular protein translocation, membrane receptor protein interactions, and non-invasive in vivo imaging, we are determining the molecular bases (chromatin remodeling and signaling pathways) for changing the nuclear function of embryonic and adult stem cells.
Other Recent Work: our laboratory has worked in a broad range of research disciplines in the past. Most recently, we have studied the RNAi pathway and angiogenesis. Members of our lab have developed a technology to generate shRNA libraries. In addition, we have helped to understand better how the RNA interference pathway operates. Angiogenesis is a critical component of stroke, head injury, vascular malformations, development and brain tumor growth to name a few. Recently we have found a means for enhancing VEGF's beneficial effects while abrogating its deleterious effects.
Publications
- A single cell bioengineering approach to elucidate mechanisms of adult stem cell self-renewal. Integr Biol (Camb). 2012; (4): 360-7
- Redefining differentiation: Reshaping our ends. Nat Cell Biol. 2012; (6): 558
- DNA demethylation dynamics. Cell. 2011; (6): 866-72
- Re"evolutionary" regenerative medicine. JAMA. 2011; (1): 87-8
- Reprogramming towards pluripotency requires AID-dependent DNA demethylation. Nature. 2010; (7284): 1042-7
- Short telomeres and stem cell exhaustion model Duchenne muscular dystrophy in mdx/mTR mice. Cell. 2010; (7): 1059-71
Help